Nexgel (NXGLW) Cash from Investing Activities (2020 - 2025)
Nexgel (NXGLW) reported Cash from Investing Activities of -$40000.0 for Q4 2025, up 36.51% on a YoY basis from -$29302.3 in Q4 2024, and down 400.0% quarter-over-quarter from -$8000.0 in Q3 2025.
Nexgel (NXGLW) Cash from Investing Activities (2020 - 2025) Analysis & Trends
Nexgel has reported Cash from Investing Activities for 6 years, with the latest figure at -$40000.0 in Q4 2025.
- For the quarter ending Q4 2025, Cash from Investing Activities rose 36.51% year-over-year to -$40000.0; the trailing twelve-month figure through Dec 2025 stood at -$119000.0 (up 84.65% YoY), and the FY2025 full-year result was -$68000.0, up 91.23% from the prior year.
- Cash from Investing Activities for Q4 2025 stood at -$40000.0, down from -$8000.0 in the prior quarter.
- The five-year high for Cash from Investing Activities was $4.1 million in Q2 2023, with the low at -$5.4 million in Q2 2022.
- Historically, Cash from Investing Activities has averaged -$139437.5 across 5 years, with a median of -$51500.0 in 2024.
- Annual changes were most pronounced in 2021 — Cash from Investing Activities tumbled 26600.0% — and 2022, when it surged 290.91%.
- Nexgel's Cash from Investing Activities stood at $121000.0 in 2021, then surged by 290.91% to $473000.0 in 2022, then tumbled by 157.72% to -$273000.0 in 2023, then soared by 76.92% to -$63000.0 in 2024, then jumped by 36.51% to -$40000.0 in 2025.
- The last three Cash from Investing Activities figures came in at -$40000.0 (Q4 2025), -$8000.0 (Q3 2025), and -$63000.0 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | -914.50 Mn |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -139.00 Mn |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | -96.00 Mn |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | -58.03 Mn |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | -42.70 Mn |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | -77.00 Mn |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -90.00 Mn |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | -131.58 Mn |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -133.00 Mn |
| 10 | Nexgel | - | - | 819,000.00 | -40,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -40,000.00 |
| Dec 31, 2025 | -40,000.00 |
| Sep 30, 2025 | -8,000.00 |
| Sep 30, 2025 | -8,000.00 |
| Dec 31, 2024 | -63,000.00 |
| Dec 31, 2024 | -63,000.00 |
| Sep 30, 2024 | -8,000.00 |
| Sep 30, 2024 | -8,000.00 |
| Jun 30, 2024 | -586,000.00 |
| Jun 30, 2024 | -586,000.00 |
| Mar 31, 2024 | -118,000.00 |
| Mar 31, 2024 | -118,000.00 |
| Dec 31, 2023 | -273,000.00 |
| Dec 31, 2023 | -273,000.00 |
| Sep 30, 2023 | 210,000.00 |
| Sep 30, 2023 | 210,000.00 |
| Jun 30, 2023 | 4.12 Mn |
| Jun 30, 2023 | 4.12 Mn |
| Mar 31, 2023 | 397,000.00 |
| Mar 31, 2023 | 397,000.00 |